Dr Ashish Awasthi, MD | |
901 W Main St Ste 205, Cn 5050, Freehold, NJ 07728-2537 | |
(732) 866-0800 | |
(732) 866-0018 |
Full Name | Dr Ashish Awasthi |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 32 Years |
Location | 901 W Main St Ste 205, Freehold, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033146618 | NPI | - | NPPES |
P00399679 | Other | RR MEDICARE | |
P3723526 | Other | NJ | OXFORD |
7958271 | Other | AETNA PPO | |
0126689 | Other | NJ | GHI PPO |
1322049 | Other | AETNA HMO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 25MA08091400 (New Jersey) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Centrastate Medical Center | Freehold, NJ | Hospital |
Robert Wood Johnson University Hospital | New brunswick, NJ | Hospital |
Saint Peter's University Hospital | New brunswick, NJ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Robert Wood Johnson Physician Enterprise | 5597917633 | 47 |
News Archive
Advanced Sterilization Products (ASP), a leading global infection prevention solution provider, announced today the acquisition by its French affiliate, Apsis S.A.S., of Gloster Europe, a privately held developer of innovative disinfection processes and technologies to prevent healthcare-acquired infections. Terms of the acquisition were not disclosed.
Researchers from Virginia Commonwealth University (VCU) Massey Cancer Center have discovered a new signaling pathway in sterile inflammation that could impact the treatment of diseases such as cancer, multiple sclerosis and rheumatoid arthritis.
Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics™, today announced that its collaboration and license agreement with AstraZeneca for the global development and commercialization of TC-5214 for major depressive disorder (MDD) has become effective as a result of early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.
Levels of inflammatory proteins, so-called cytokines, are elevated in the blood even before the onset of arthritic rheumatism. This means that such blood samples could be used to predict the development of the disease and thereby make it possible to prevent the pathological process, according to an article by Umeå researcher Solbritt Rantapää-Dahlqvist and her associates in the journal Arthritis and Rheumatism.
› Verified 7 days ago
Entity Name | Robert Wood Johnson Physician Enterprise |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1245587922 PECOS PAC ID: 5597917633 Enrollment ID: O20121218000345 |
News Archive
Advanced Sterilization Products (ASP), a leading global infection prevention solution provider, announced today the acquisition by its French affiliate, Apsis S.A.S., of Gloster Europe, a privately held developer of innovative disinfection processes and technologies to prevent healthcare-acquired infections. Terms of the acquisition were not disclosed.
Researchers from Virginia Commonwealth University (VCU) Massey Cancer Center have discovered a new signaling pathway in sterile inflammation that could impact the treatment of diseases such as cancer, multiple sclerosis and rheumatoid arthritis.
Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics™, today announced that its collaboration and license agreement with AstraZeneca for the global development and commercialization of TC-5214 for major depressive disorder (MDD) has become effective as a result of early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.
Levels of inflammatory proteins, so-called cytokines, are elevated in the blood even before the onset of arthritic rheumatism. This means that such blood samples could be used to predict the development of the disease and thereby make it possible to prevent the pathological process, according to an article by Umeå researcher Solbritt Rantapää-Dahlqvist and her associates in the journal Arthritis and Rheumatism.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Ashish Awasthi, MD 901 W Main St Ste 205, Cn 5050, Freehold, NJ 07728-2537 Ph: (732) 866-0800 | Dr Ashish Awasthi, MD 901 W Main St Ste 205, Cn 5050, Freehold, NJ 07728-2537 Ph: (732) 866-0800 |
News Archive
Advanced Sterilization Products (ASP), a leading global infection prevention solution provider, announced today the acquisition by its French affiliate, Apsis S.A.S., of Gloster Europe, a privately held developer of innovative disinfection processes and technologies to prevent healthcare-acquired infections. Terms of the acquisition were not disclosed.
Researchers from Virginia Commonwealth University (VCU) Massey Cancer Center have discovered a new signaling pathway in sterile inflammation that could impact the treatment of diseases such as cancer, multiple sclerosis and rheumatoid arthritis.
Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics™, today announced that its collaboration and license agreement with AstraZeneca for the global development and commercialization of TC-5214 for major depressive disorder (MDD) has become effective as a result of early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.
Levels of inflammatory proteins, so-called cytokines, are elevated in the blood even before the onset of arthritic rheumatism. This means that such blood samples could be used to predict the development of the disease and thereby make it possible to prevent the pathological process, according to an article by Umeå researcher Solbritt Rantapää-Dahlqvist and her associates in the journal Arthritis and Rheumatism.
› Verified 7 days ago
Dr. Kunal Gupta, M.D.,,M.B.A Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 222 Schanck Rd, Suite 302, Freehold, NJ 07728 Phone: 732-577-1999 Fax: 732-845-5356 | |
Dr. Colin Christopher Brown, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 222 Schanck Rd, Suite 302, Freehold, NJ 07728 Phone: 732-577-1999 Fax: 732-845-5356 | |
Dr. Rudolph Harold Borgersen, Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 501 Stillwells Corner Rd, Freehold, NJ 07728 Phone: 732-780-3330 Fax: 732-780-4385 | |
Dr. Fiolakemi Sowemimo, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 901 W Main St, Suite 103, Freehold, NJ 07728 Phone: 732-252-6688 Fax: 732-761-9705 | |
Dr. Pinakin Chimanbhai Patel, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12 Russell Rd, Freehold, NJ 07728 Phone: 732-577-7977 | |
Dr. Bhavesh Vasant Balar, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 326 Professional View Dr, Freehold, NJ 07728 Phone: 732-431-8400 Fax: 732-431-0114 |